TKIs work by targeting specific tyrosine kinases that are involved in the signaling pathways of cancer cells. These kinases are often overactive in cancerous cells, leading to uncontrolled cell division and tumor growth. By blocking these enzymes, TKIs can disrupt these signaling pathways, inhibiting the proliferation and survival of cancer cells.
